[go: up one dir, main page]

PT98134A - Processo para a preparacao de mono- ou dissulfato do produto (ws7622a) obtido da cultura de uma estirpe de streptomyces resbtomycificus n 0. 7622 e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de mono- ou dissulfato do produto (ws7622a) obtido da cultura de uma estirpe de streptomyces resbtomycificus n 0. 7622 e de composicoes farmaceuticas que os contem

Info

Publication number
PT98134A
PT98134A PT98134A PT9813491A PT98134A PT 98134 A PT98134 A PT 98134A PT 98134 A PT98134 A PT 98134A PT 9813491 A PT9813491 A PT 9813491A PT 98134 A PT98134 A PT 98134A
Authority
PT
Portugal
Prior art keywords
ws7622a
pharmaceutical compositions
resbtomycificus
streptomyces
culture
Prior art date
Application number
PT98134A
Other languages
English (en)
Other versions
PT98134B (pt
Inventor
Masakuni Okuhara
Shigehiro Takase
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT98134A publication Critical patent/PT98134A/pt
Publication of PT98134B publication Critical patent/PT98134B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2/00Peptides of undefined number of amino acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
PT98134A 1990-06-29 1991-06-28 Processo para a preparacao de mono- ou dissulfato do produto (ws7622a) obtido da cultura de uma estirpe de streptomyces resbtomycificus n 0. 7622 e de composicoes farmaceuticas que os contem PT98134B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (2)

Publication Number Publication Date
PT98134A true PT98134A (pt) 1992-06-30
PT98134B PT98134B (pt) 1998-12-31

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98134A PT98134B (pt) 1990-06-29 1991-06-28 Processo para a preparacao de mono- ou dissulfato do produto (ws7622a) obtido da cultura de uma estirpe de streptomyces resbtomycificus n 0. 7622 e de composicoes farmaceuticas que os contem

Country Status (22)

Country Link
US (2) US5292510A (pt)
EP (1) EP0465895B1 (pt)
JP (1) JP2663763B2 (pt)
KR (1) KR100198693B1 (pt)
CN (1) CN1073115C (pt)
AT (1) ATE138074T1 (pt)
AU (1) AU640241B2 (pt)
CA (1) CA2045761C (pt)
DE (1) DE69119488T2 (pt)
DK (1) DK0465895T3 (pt)
ES (1) ES2087178T3 (pt)
FI (1) FI106554B (pt)
GB (1) GB9014546D0 (pt)
GR (1) GR3020184T3 (pt)
HU (1) HU213398B (pt)
IE (1) IE75702B1 (pt)
IL (1) IL98394A (pt)
NO (1) NO301643B1 (pt)
PH (1) PH31239A (pt)
PT (1) PT98134B (pt)
RU (1) RU2087482C1 (pt)
ZA (1) ZA914349B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519354B1 (en) * 1991-06-18 1997-12-10 Fujisawa Pharmaceutical Co., Ltd. A prophylactic/therapeutic composition containing WS7622A for preventing or treating disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
EP1057491B1 (en) * 1998-02-24 2013-06-19 Astellas Pharma Inc. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心) 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
HUT58351A (en) 1992-02-28
RU2087482C1 (ru) 1997-08-20
CN1057655A (zh) 1992-01-08
NO301643B1 (no) 1997-11-24
EP0465895B1 (en) 1996-05-15
CA2045761A1 (en) 1991-12-30
HU912198D0 (en) 1991-12-30
DE69119488D1 (de) 1996-06-20
IE75702B1 (en) 1997-09-10
PH31239A (en) 1998-06-18
ATE138074T1 (de) 1996-06-15
IE912047A1 (en) 1992-01-01
IL98394A0 (en) 1992-07-15
CA2045761C (en) 1999-09-21
GB9014546D0 (en) 1990-08-22
PT98134B (pt) 1998-12-31
FI912914L (fi) 1991-12-30
DE69119488T2 (de) 1996-10-02
KR100198693B1 (ko) 1999-06-15
US5364624A (en) 1994-11-15
JP2663763B2 (ja) 1997-10-15
NO912561L (no) 1991-12-30
JPH04279600A (ja) 1992-10-05
AU7939491A (en) 1992-01-09
FI912914A0 (fi) 1991-06-17
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
DK0465895T3 (da) 1996-06-03
US5292510A (en) 1994-03-08
CN1073115C (zh) 2001-10-17
KR920000920A (ko) 1992-01-29
ZA914349B (en) 1992-03-25
AU640241B2 (en) 1993-08-19
FI106554B (fi) 2001-02-28
EP0465895A1 (en) 1992-01-15
ES2087178T3 (es) 1996-07-16
GR3020184T3 (en) 1996-09-30
NO912561D0 (no) 1991-06-28

Similar Documents

Publication Publication Date Title
MX9203633A (es) Derivados de leucina y composiciones farmaceuticas que los contienen.
SE8504254D0 (sv) Antibiotiska foreningar och deras framstellning
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2083123T3 (es) Nuevos derivados de aril-etil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
DK0623021T3 (da) 4"-deoxyerythromycinderivater
PT89729A (pt) Processo para a preparacao de derivados de cefalosporina e de composicoes farmaceuticas que os contem
PT98134A (pt) Processo para a preparacao de mono- ou dissulfato do produto (ws7622a) obtido da cultura de uma estirpe de streptomyces resbtomycificus n 0. 7622 e de composicoes farmaceuticas que os contem
PT91468A (pt) Processo para a preparacao de um novo antibiotico mersacidina e de composicoes farmaceuticas que o contem
FI901237A0 (fi) Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning.
PT90614A (pt) Processo para a preparacao de tienil-piperazinonas e de composicoes farmaceuticas que os contem
ES2104295T3 (es) Derivados ciclopeptidicos de la angiopeptina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2061712T3 (es) Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
PT97663A (pt) Processo de preparacao de 3'-desamino-4'-desoxi-4'-amino-8-fluoro-antraciclinas, de composicoes farmaceuticas que as contem e de seus intermediarios
MX9301668A (es) Monohidratos cristalinos de– clorhidrato de endo-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-benc imidazol-1-carboxamida y del clorhidrato de endo-3-etil-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo- 1h-bencimidazol-1-car.
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза
PT93597A (pt) Processo para a preparacao de derivados cefalosporanicos polares e de composicoes farmaceuticas que os contem
ES2130392T3 (es) Procedimiento para la preparacion de acido clavulanico.
PT93581A (pt) Processo para a preparacao de derivados cefalosporanicos e de composicoes farmaceuticas que os contem
PT97255A (pt) Processo para a preparacao de 3-tia-alquil-flavonas e de 3-oxa-alquil flavonas e substituidas e de composicoes farmaceuticas que as contem

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920108

FG3A Patent granted, date of granting

Effective date: 19980909

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20050309